Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
Garon, Edward B, Dr, Ciuleanu, Tudor-Eliade, Prof, Arrieta, Oscar, MD, Prabhash, Kumar, Prof, Syrigos, Konstantinos N, Prof, Goksel, Tuncay, Prof, Park, Keunchil, Prof, Gorbunova, Vera, MD, Kowalyszyn, Ruben Dario, MD, Pikiel, Joanna, MD, Czyzewicz, Grzegorz, MD, Orlov, Sergey V, Prof, Lewanski, Conrad R, MD, Thomas, Michael, Prof, Bidoli, Paolo, MD, Dakhil, Shaker, MD, Gans, Steven, MD, Kim, Joo-Hang, Prof, Grigorescu, Alexandru, Prof, Karaseva, Nina, MD, Reck, Martin, MD, Cappuzzo, Federico, MD, Alexandris, Ekaterine, MS, Sashegyi, Andreas, PhD, Yurasov, Sergey, MD, Pérol, Maurice, MD
Published in The Lancet (British edition) (23.08.2014)
Published in The Lancet (British edition) (23.08.2014)
Get full text
Journal Article
Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
SIOW MING LEE, LEWANSKI, Conrad R, COUNSELL, Nicholas, OTTENSMEIER, Christian, BATES, Andrew, PATEL, Nirali, WADSWORTH, Christina, YENTING NGAI, HACKSHAW, Allan, FAIVRE-FINN, Corinne
Published in JNCI : Journal of the National Cancer Institute (01.07.2014)
Published in JNCI : Journal of the National Cancer Institute (01.07.2014)
Get full text
Journal Article
Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy
Pérol, Maurice, Ciuleanu, Tudor-Eliade, Arrieta, Oscar, Prabhash, Kumar, Syrigos, Konstantinos N, Goksel, Tuncay, Park, Keunchil, Kowalyszyn, Ruben Dario, Pikiel, Joanna, Lewanski, Conrad R, Thomas, Michael, Dakhil, Shaker, Kim, Joo-Hang, Karaseva, Nina, Yurasov, Sergey, Zimmermann, Annamaria, Lee, Pablo, Carter, Gebra Cuyun, Reck, Martin, Cappuzzo, Federico, Garon, Edward B
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2016)
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2016)
Get full text
Journal Article
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)
Morgensztern, Daniel, Cobo, Manuel, Ponce Aix, Santiago, Postmus, Pieter E., Lewanski, Conrad R., Bennouna, Jaafar, Fischer, Jürgen R., Juan‐Vidal, Oscar, Stewart, David J., Fasola, Gianpiero, Ardizzoni, Andrea, Bhore, Rafia, Wolfsteiner, Marianne, Talbot, Denis C., Jin Ong, Teng, Govindan, Ramaswamy, on behalf of the ABOUND.2L+ Investigators
Published in Cancer (15.12.2018)
Published in Cancer (15.12.2018)
Get full text
Journal Article
Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer
Paz-Ares, Luis G, Pérol, Maurice, Ciuleanu, Tudor-Eliade, Kowalyszyn, Ruben Dario, Reck, Martin, Lewanski, Conrad R, Syrigos, Konstantinos, Arrieta, Oscar, Prabhash, Kumar, Park, Keunchil, Pikiel, Joanna, Göksel, Tuncay, Lee, Pablo, Zimmermann, Anna, Carter, Gebra Cuyun, Alexandris, Ekaterine, Garon, Edward B
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2017)
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2017)
Get full text
Journal Article
Final overall survival (OS) results of the phase III PROCLAIM trial: Pemetrexed (Pem), cisplatin (Cis) or etoposide (Eto), Cis plus thoracic radiation therapy (TRT) followed by consolidation cytotoxic chemotherapy (CTX) in locally advanced nonsquamous non-small cell lung cancer (nsNSCLC)
Senan, Suresh, Brade, Anthony M., Wang, Luhua, Vansteenkiste, Johan F., Dakhil, Shaker R., Biesma, Bonne, Martinez Aguillo, Maite, Aerts, Joachim, Govindan, Ramaswamy, Rubio-Viqueira, Belén, Lewanski, Conrad R., Gandara, David R., Choy, Hak, Mok, Tony, Hossain, Anwar, Iscoe, Neill Allan, Treat, Joseph, Koustenis, Andrew G., Chouaki, Nadia, Vokes, Everett E.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Pegylated liposomal adriamycin: a review of current and future applications
Lewanski, Conrad R, Stewart, Simon
Published in Pharmaceutical Science & Technology Today (01.12.1999)
Published in Pharmaceutical Science & Technology Today (01.12.1999)
Get full text
Book Review
Journal Article
Antibiotic treatment prior to immune checkpoint inhibitor therapy as a tumor-agnostic predictive correlate of response in routine clinical practice
Pinato, David James, Howlett, Sarah, Ottaviani, Diego, Urus, Heather, Patel, Aisha, Mineo, Takashi, Brock, Cathryn, Power, Danielle, Hatcher, Olivia, Falconer, Alison, Ingle, Manasi, Brown, Anna, Gujral, Dorothy M., Partridge, Sarah, Sarwar, Naveed, Gonzalez, Michael, Bendle, Maggie, Lewanski, Conrad R., Newsom-Davis, Thomas, Bower, Mark
Published in Journal of clinical oncology (10.03.2019)
Published in Journal of clinical oncology (10.03.2019)
Get full text
Journal Article
Non-classical response measured by immune-modified RECIST and post-progression treatment effects of atezolizumab in 2L/3L NSCLC: Results from the randomized phase II study POPLAR
Mazieres, Julien, Fehrenbacher, Louis, Rittmeyer, Achim, Spira, Alexander I., Park, Keunchil, Smith, David A., Artal-Cortes, Angel, Lewanski, Conrad R., Braiteh, Fadi S., Yi, Jing, He, Pei, Kowanetz, Marcin, Waterkamp, Daniel, Ballinger, Marcus, Chen, Daniel S., Sandler, Alan, Vansteenkiste, Johan F.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Updated survival and biomarker analyses of a randomized phase II study of atezolizumab vs docetaxel in 2L/3L NSCLC (POPLAR)
Smith, David A., Vansteenkiste, Johan F., Fehrenbacher, Louis, Park, Keunchil, Mazieres, Julien, Rittmeyer, Achim, Artal-Cortes, Angel, Lewanski, Conrad R., Braiteh, Fadi S., Yi, Jing, He, Pei, Zou, Wei, Kowanetz, Marcin, Waterkamp, Daniel, Ballinger, Marcus, Chen, Daniel S., Sandler, Alan, Spira, Alexander I.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Exploratory analysis of safety by histology and efficacy in a nonsquamous NSCLC subgroup in REVEL: A randomized phase III study of ramucirumab (RAM) plus docetaxel (DOC) vs DOC for second-line treatment of stage IV non-small-cell lung cancer (NSCLC)
Paz-Ares, Luis, Perol, Maurice, Ciuleanu, Tudor-Eliade, Kowalyszyn, Ruben Dario, Reck, Martin, Lewanski, Conrad R., Syrigos, Konstantinos N., Arrieta, Oscar, Prabhash, Kumar, Park, Keunchil, Pikiel, Joanna, Göksel, Tuncay, Lee, Pablo Sang, Zimmerman, Annamaria, Treat, Joseph, Ferry, David, Melemed, Allen S., Cuyun Carter, Gebra, Alexandris, Ekaterine, Garon, Edward B.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
REVEL: A randomized, double-blind, phase III study of docetaxel (DOC) and ramucirumab (RAM; IMC-1121B) versus DOC and placebo (PL) in the second-line treatment of stage IV non-small cell lung cancer (NSCLC) following disease progression after one prior platinum-based therapy
Perol, Maurice, Ciuleanu, Tudor-Eliade, Arrieta, Oscar, Prabhash, Kumar, Syrigos, Konstantinos N., Göksel, Tuncay, Park, Keunchil, Kowalyszyn, Ruben Dario, Pikiel, Joanna, Czyzewicz, Grzegorz, Orlov, Sergey, Lewanski, Conrad R., Alexandris, Ekaterine, Zimmerman, Annamaria, Chouaki, Nadia, John, William J., Yurasov, Sergey, Garon, Edward B.
Published in Journal of clinical oncology (20.06.2014)
Published in Journal of clinical oncology (20.06.2014)
Get full text
Journal Article
REVEL: A randomized, double-blind, phase III study of docetaxel (DOC) and ramucirumab (RAM; IMC-1121B) versus DOC and placebo (PL) in the second-line treatment of stage IV non-small cell lung cancer (NSCLC) following disease progression after one prior platinum-based therapy
Perol, Maurice, Ciuleanu, Tudor-Eliade, Arrieta, Oscar, Prabhash, Kumar, Syrigos, Konstantinos N., Göksel, Tuncay, Park, Keunchil, Kowalyszyn, Ruben Dario, Pikiel, Joanna, Czyzewicz, Grzegorz, Orlov, Sergey, Lewanski, Conrad R., Alexandris, Ekaterine, Zimmerman, Annamaria, Chouaki, Nadia, John, William J., Yurasov, Sergey, Garon, Edward B.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
GARON, Edward B, CIULEANU, Tudor-Eliade, CZYZEWICZ, Grzegorz, ORLOV, Sergey V, LEWANSKI, Conrad R, THOMAS, Michael, BIDOLI, Paolo, DAKHIL, Shaker, GANS, Steven, KIM, Joo-Hang, GRIGORESCU, Alexandru, KARASEVA, Nina, ARRIETA, Oscar, RECK, Martin, CAPPUZZO, Federico, ALEXANDRIS, Ekaterine, SASHEGYI, Andreas, YURASOV, Sergey, PEROL, Maurice, PRABHASH, Kumar, SYRIGOS, Konstantinos N, GOKSEL, Tuncay, PARK, Keunchil, GORBUNOVA, Vera, KOWALYSZYN, Ruben Dario, PIKIEL, Joanna
Published in The Lancet (British edition) (2014)
Get full text
Published in The Lancet (British edition) (2014)
Journal Article